Enfusion Inc. (ENFN) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Enfusion Inc. (ENFN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

10.82

0.01 (0.09%)

At close: Jan 14, 2025, 3:59 PM

10.81

-0.09%

After-hours Jan 14, 2025, 07:00 PM EST

undefined% (undefined)

Bid	10.8
Market Cap	1.02B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.04
PE Ratio (ttm)	270.5
Forward PE	n/a
Analyst	Sell

Ask	17.29
Volume	2,426,513
Avg. Volume (20D)	546,957
Open	10.81
Previous Close	10.81
Day's Range	10.75 - 10.91
52-Week Range	7.52 - 11.38
Beta	undefined

About ENFN

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and e...

[Show more]

Industry Software - Application

Sector Technology

IPO Date Oct 21, 2021

Employees 1,102

Stock Exchange NYSE

Ticker Symbol ENFN

Website https://www.enfusion.com

Analyst Forecast

According to 6 analyst ratings, the average rating for ENFN stock is "Sell." The 12-month stock price forecast is $9, which is a decrease of -16.82% from the latest price.

Buy 16.67%

Hold 33.33%

Sell 50.00%

Stock Forecasts

Next Earnings Release

Enfusion Inc. is scheduled to release its earnings on Mar 11, 2025, before market opens.
Analysts project revenue of $54.39M, reflecting a 17.00% YoY growth and earnings per share of 0.06, making a 50.00% increase YoY.

Why Price Moved

3 months ago · Source

+5.03%

Enfusion shares are trading higher after the compa... Unlock content with Pro Subscription

10 months ago · Source

+9.86%

Enfusion shares are trading higher after the company reported better-than-expected Q4 revenue results and issued FY24 revenue guidance.

News

2 days ago · businesswire.com

ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enfusion, Inc. (...

1 day ago · businesswire.com

ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. With the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. with the Schall Law Firm.

1 day ago · https://thefly.com

BofA moves to No Rating on Enfusion after Clearwater Analytics deal

Enfusion +0.84 (+8.41%) Clearwater Analytics -1.48 (-5.47%)

1 day ago · https://thefly.com

Clearwater-Enfusion merger makes sense strategically, says Oppenheimer

Clearwater Analytics + Enfusion +0.76 (+7.61%)

1 day ago · techcrunch.com

Clearwater agrees to buy investment management platform Enfusion for $1.5B

Clearwater Analytics, a company developing accounting, compliance, and risk reporting tools for asset managers, said on Monday it has entered into a definitive agreement to acquire investment manageme...

2 days ago · businesswire.com

ENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics for $5.85 per share in cash and $5.40...

2 days ago · reuters.com

Clearwater Analytics to acquire Enfusion in $1.5 bln deal

Clearwater Analytics has agreed to acquire investment management platform Enfusion in a $1.5 billion cash-and-stock deal, the companies said on Monday.

2 days ago · businesswire.com

Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

BOISE, Idaho & CHICAGO--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive merger agreement fo...

3 weeks ago · seekingalpha.com

Enfusion: Revenue Growth Should Start To Accelerate

I maintain a buy rating for ENFN, anticipating revenue growth to exceed 20% due to improving macro conditions and solid execution. The macro environment has shown signs of turnaround, with rate cuts a...

1 month ago · businesswire.com

Enfusion To Present at Upcoming Investor Events

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enf...

2 months ago · seekingalpha.com

Enfusion, Inc. (ENFN) Q3 2024 Earnings Call Transcript

Enfusion, Inc. (NYSE:ENFN ) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Bill Wright - Head, IR Oleg Movchan - Chief Executive Officer Bradley Herring - Chief Fina...

2 months ago · zacks.com

Here's What Key Metrics Tell Us About Enfusion (ENFN) Q3 Earnings

The headline numbers for Enfusion (ENFN) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street est...

2 months ago · zacks.com

Enfusion, Inc. (ENFN) Q3 Earnings and Revenues Miss Estimates

Enfusion, Inc. (ENFN) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago.

2 months ago · businesswire.com

Enfusion Announces Third Quarter 2024 Results